339 related articles for article (PubMed ID: 15782496)
21. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
Tengvall S; Josefsson A; Holmgren J; Harandi AM
J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
[TBL] [Abstract][Full Text] [Related]
22. [Construction of herpes simplex virus type I glycoprotein D DNA vaccine and its preliminary study].
Zhu MZ; Liu HW; Liu XJ; Han YH; Yang BL; Song GX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):67-70. PubMed ID: 12905843
[TBL] [Abstract][Full Text] [Related]
23. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
Chen G; Chen H; Guo H; Zheng H
Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
[TBL] [Abstract][Full Text] [Related]
25. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.
Rompato G; Ling E; Chen Z; Van Kruiningen H; Garmendia AE
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):151-60. PubMed ID: 16162362
[TBL] [Abstract][Full Text] [Related]
26. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.
Guo H; Chen G; Lu F; Chen H; Zheng H
Chin Med J (Engl); 2001 Mar; 114(3):317-20. PubMed ID: 11780322
[TBL] [Abstract][Full Text] [Related]
27. [Construction of Ag85B DNA vaccine for Mycobacterium tuberculosis and its immunogenicities].
You L; Zhao Y; Gao C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):736-9. PubMed ID: 11930703
[TBL] [Abstract][Full Text] [Related]
28. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
Li H; Li R; Zhong S; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):291-4. PubMed ID: 17428378
[TBL] [Abstract][Full Text] [Related]
29. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
30. 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.
Arai H; Xin KQ; Hamajima K; Lu Y; Watabe S; Takahashi T; Toda S; Okuda K; Kudoh I; Suzuki M; Okuda K
Gene Ther; 2000 Apr; 7(8):694-702. PubMed ID: 10800093
[TBL] [Abstract][Full Text] [Related]
31. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
Jamali A; Roostaee MH; Soleimanjahi H; Ghaderi Pakdel F; Bamdad T
Comp Immunol Microbiol Infect Dis; 2007 Mar; 30(2):71-80. PubMed ID: 17126902
[TBL] [Abstract][Full Text] [Related]
32. [A kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccination].
Arefian E; Bamdad T; Soleimanjahi H; Akhood MR; Parsania M; Ghaemi A
Mol Biol (Mosk); 2009; 43(3):422-8. PubMed ID: 19548528
[TBL] [Abstract][Full Text] [Related]
33. [Construction of the eukaryotic expression vector with IL-2 gene and VP2 gene of PPV and research on immunogenicity].
Cui BA; Wei ZY; Wang XB; Huang KH; Jin XX; Dong ZJ; Zheng LL
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):425-30. PubMed ID: 16755922
[TBL] [Abstract][Full Text] [Related]
34. [Enhancement of the protective effect of SjC23 DNA vaccine against Schistosoma japonicum infection by immunostimulatory sequence].
Zhao S; Zhu YC; Harn DA; Si J; Ren JG; Yin XR; He W; Liang YS; Xu M; Xu YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 16042196
[TBL] [Abstract][Full Text] [Related]
35. Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants.
Kim JJ; Yang JS; Dang K; Manson KH; Weiner DB
Clin Cancer Res; 2001 Mar; 7(3 Suppl):882s-889s. PubMed ID: 11300487
[TBL] [Abstract][Full Text] [Related]
36. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
Sin JI; Bagarazzi M; Pachuk C; Weiner DB
DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
38. [Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica].
Gan Y; Shi YE; Bu LY; Ning CX; Zhu HG
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):193-8. PubMed ID: 15854467
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.
Zhu M; Xu X; Liu H; Liu X; Wang S; Dong F; Yang B; Song G
J Med Microbiol; 2003 Mar; 52(Pt 3):223-228. PubMed ID: 12621087
[TBL] [Abstract][Full Text] [Related]
40. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
Chen ZH; Guo X; Ge XN; Jia H; Yang HC
Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
